Papillary Thyroid Carcinoma Metastasis to the Lumbar Spine Masquerading as a Schmorl’s Node

다국어 초록 (Multilingual Abstract)

A Schmorl’s node is a common incidental finding encountered during radiologic imaging. Despite the vertebral body being a common site of metastatic disease, a lytic lesion adjacent to an endplate with typical imaging features can often confidently be called a Schmorl’s node. This is a case report of a patient with a single well-defined FDG-avid papillary thyroid carcinoma metastasis to the spine that had imaging findings characteristic of a Schmorl’s node on CT and MRI. This case is important to consider as it demonstrates that the imaging characteristics of metastatic disease and Schmorl’s nodes can overlap.

참고문헌 (Reference)

1 Gandolfi G, "Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma" 28976-, 2014

2 Giovanella L, "Thyroglobulin levels and thyroglobulin doubling time independently predict a positive(18)F-FDG PET/CT scan in patients with biochemical recurrence of differentiated thyroid carcinoma" 40 : 874-880, 2013

3 Kebebew E, "The prevalence and prognostic value of BRAFmutation in thyroid cancer" 246 : 466-471, 2007

4 Dar G, "Schmorl’s nodes distribution in the human spine and its possible etiology" 19 : 670-675, 2010

5 Kyere KA, "Schmorl’s nodes" 21 : 2115-2121, 2012

6 Singh H, "Schmorl’s node mimicking metastasis in a patient with breast cancer" 2012

7 Chen YK, "Schmorl’s node may cause an increased FDG activity" 36 : 494-495, 2011

8 Pfirrmann CW, "Schmorl nodes of the thoracic and lumbar spine : radiographic-pathologic study of prevalence, characterization, and correlation with degenerative changes of 1, 650 spinal levels in 100 cadavers" 219 : 368-374, 2001

9 Cooper DS, "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer" 2009

10 WangW, "Resistance of [18 F]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine" 11 : 1169-1175, 2001

11 Ma C, "Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases" 2009

12 Ito Y, "Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung and bone : analysis of 5768 patients with average 10-year follow-up" 36 : 1274-1278, 2012

13 Ma C, "Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning" 46 : 1473-1480, 2005

14 Jensen MC, "Magnetic resonance imaging of the lumbar spine in people without back pain" 331 : 69-73, 1994

15 Ma C, "Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?" 46 : 1164-1170, 2005

16 Stojadinovic A, "Hurthle cell carcinoma : a critical histopathologic appraisal" 19 : 2616-2625, 2001

17 Coulier B, "Giant fatty Schmorl’s node : CT findings in four patients" 34 : 29-34, 2005

18 Hauger O, "Giant cystic Schmorl’s nodes : imaging findings in six patients" 176 : 969-972, 2001

19 Zeng W, "Giant Schmorl’s node : another cause of increased FDG activity and intense uptake on bone scan" 50 (50): 1032-, 2009

20 Lin CY, "Evaluation of Schmorl’s nodes using F-18 FDG PET/CT" 2012

21 Wu HT, "Edematous Schmorl’s nodes on thoracolumbar MR imaging : characteristic patterns and changes over time" 35 : 212-219, 2006

22 Ross JS, "Diagnostic imaging:spine" LippincottWilliams & Wilkins 2010

23 Yang K, "BRAFV600E mutation associated with non-radioiodine-avid status in distant metastatic papillary thyroid carcinoma" 39 : 675-679, 2014